Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has promoted Patrick Meyer, Ph.D. to Global Head BD Sales and Alliance Management within the business development team, effective June 1, 2024.
 
In this newly created position, Meyer will oversee global Business Development processes and handle key account management. As Global Head BD Sales and Alliance Management, all business development directors supporting the Milford and Laupheim manufacturing sites will report directly to him.
 
Moreover, he will collaborate closely with the BD team at the Stevenage site as well as the Alliance Management team, which focuses on the company’s strategic CDMO partnerships, offering clients integrated services along the full value chain.
 
He will report directly to Federico Pollano, Senior Vice President Business Development & Client Program Management and Member of the Executive Committee.
 
 “Patrick’s promotion underpins our commitment to client centricity. Patrick has continuously demonstrated his expertise in international business development and cultivated an in-depth strategic understanding of our services and operations,” said Pollano. “He brings exceptional skills to this role, further strengthening our entire business development team with his forward-thinking leadership, strategic insights, and ability to foster strong client relationships.”
 
Meyer said: “I am thrilled to take on this new role within the business development team, as it allows me to refocus on what I am most passionate about – our clients. I look forward to strengthening relationships with new and existing clients and building new partnerships. Together with our dedicated team, I will work to exceed the expectations of our international clients, leveraging the expertise of our global organization. We will continue to enhance Rentschler Biopharma’s services globally, solidifying our position as a reliable and trusted partner and providing world-class solutions along the entire biopharmaceutical value chain.”
 
Meyer is a seasoned professional and expert in international business development. He has been part of Rentschler Biopharma’s business development team in various roles. He holds a Ph.D. in molecular medicine and cellular biology from Ulm University, Germany.